1. Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung Cancer 
Didier Lardinois, MD, Hans Suter, MD, Hassan Hakki, MD, Valentin Rousson, PhD, Daniel Betticher, MD, Hans-Beat Ris, MD 
The Annals of Thoracic Surgery 
Volume 80, Issue 1, Pages (July 2005)
DOI: /j.athoracsur
Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Overall survival in 92 consecutive patients undergoing complete resection for non-small cell lung cancer according to the type of intraoperative mediastinal lymph-node assessment: mediastinal lymph-node dissection (MLND) versus mediastinal lymph-node sampling (MLNS): (a) all patients; (b) pathological stage I disease; (c) pathological stage II disease; (d) pathological stage IIIA disease. (— = MLND; = MLNS.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Disease-free survival in 92 consecutive patients undergoing complete resection for non-small cell lung cancer according to the type of intraoperative mediastinal lymph-node assessment: mediastinal lymph-node dissection (MLND) versus mediastinal lymph- node sampling (MLNS): (a) all patients; (b) pathological stage I disease; (c) pathological stage II disease; (d) pathological stage IIIA disease. (— = MLND; = MLNS.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions